Hippocratic AI
Funding History
| Series A · 03/2024 | $500M |
|---|---|
| Series B · 01/2025 | $1.6B |
| Series C · 11/2025 | $3.5B |
About
Hippocratic AI restricts its generative AI agents to non-diagnostic, patient-facing use cases such as chronic disease management, medication adherence, pre- and post-operative check-ins, and care-gap closure, and does not permit its agents to diagnose conditions or prescribe medication.
- totalFundingRaised
- $404M
- lastValuation
- $3.5B
- founded
- 2023
- clinicalPatientInteractions
- 10M+
- clinicalSafetyScore
- 99.9%
Overview
Hippocratic AI is a Palo Alto, California company founded in 2023 by serial entrepreneur Munjal Shah together with physicians, hospital administrators, and AI researchers to build a safety-focused large language model for healthcare.
Its non-diagnostic, patient-facing AI agents run on the company's Polaris Safety Constellation Architecture and, as of its November 2025 Series C announcement, were deployed with more than 50 health systems, payers, and pharmaceutical clients across six countries.
Private securities are speculative, illiquid, and involve risk of complete loss of principal. You should be prepared to hold private securities for an extended period; there is no assurance of a secondary market, an IPO, or other liquidity event. You are fully responsible for conducting your own due diligence. Pricing is indicative — nothing here is an offer of securities.